# Safety Study of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies

> **NCT01118819** · PHASE1 · TERMINATED · sponsor: **BioMed Valley Discoveries, Inc** · enrollment: 5 (actual)

## Conditions studied

- Solid Tumor Malignancies

## Interventions

- **BIOLOGICAL:** Clostridium novyi-NT spores

## Key facts

- **NCT ID:** NCT01118819
- **Lead sponsor:** BioMed Valley Discoveries, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-04
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** This study was terminated. An IT injection study of C. novyi-NT in patients with treatment refractory solid tumor malignancies may be viewed at NCT01924689.
- **Last updated:** 2016-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01118819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01118819, "Safety Study of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT01118819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*